Skip to main content
. Author manuscript; available in PMC: 2016 Feb 16.
Published in final edited form as: Biometrika. 2015 Jul 15;102(3):501–514. doi: 10.1093/biomet/asv028

Fig. 3.

Fig. 3

Learned decision rule for nafazodone study: patients with high mood disturbance (MOOD), poor sleep (SLEEPD2), or more severe depression symptoms (HAMD) are assigned nefazodone and cognitive behavioural therapy (Drug + CBT); others are assigned nefazodone only.